HCW Biologics Inc. short interest in 2026
In 2026, HCW Biologics Inc.'s disclosed short interest ran from 2.00% of shares outstanding on 30 Jan 2026 to 57.09% on 15 May 2026, a change of +55.09 percentage points. The year's high was 57.09% on 15 May 2026 and its low 0.88% on 13 Feb 2026, averaging 9.61% across 7 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 1.00 days on 30 Jan 2026. Full history: HCW Biologics Inc..
Cite this page
By year: 2022 · 2023 · 2024 · 2025 · 2026
2026 in figures
- Start of year
- 2.00% (30 Jan 2026)
- End of year
- 57.09% (15 May 2026)
- Change
- +55.09 pp
- High
- 57.09% (15 May 2026)
- Low
- 0.88% (13 Feb 2026)
- Average
- 9.61%
- Highest days to cover
- 1.00 (30 Jan 2026)
- SEC filings marked
- 6
Every report in 2026
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 30 Jan 2026 | 2.00% | 1.00 | |
| 13 Feb 2026 | 0.88% | 1.00 | |
| 27 Feb 2026 | 2.13% | 1.00 | |
| 13 Mar 2026 | 1.59% | 1.00 | |
| 31 Mar 2026 | 1.64% | 1.00 | 10-K filed, results (8-K) |
| 15 Apr 2026 | 1.94% | 1.00 | |
| 15 May 2026 | 57.09% | 1.00 | 10-Q filed, results (8-K) |
See also: HCW Biologics Inc.'s full history · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.